Provided by Tiger Trade Technology Pte. Ltd.

ResMed

226.73
+0.75000.33%
Post-market: 226.730.00000.00%19:47 EDT
Volume:651.15K
Turnover:147.02M
Market Cap:31.97B
PE:21.74
High:226.88
Open:225.79
Low:223.04
Close:225.98
52wk High:284.87
52wk Low:180.27
Shares:141.00M
Float Shares:140.00M
Volume Ratio:0.66
T/O Rate:0.47%
Dividend:2.40
Dividend Rate:1.06%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:4.85
PE(LYR):21.74

Loading ...

BofA Adjusts Price Target on ResMed to $320 From $310

MT Newswires Live
·
Jul 24

ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says

MT Newswires Live
·
Jul 22

Resmed Bulls Think Acquisition Timing Looks Awkward

Dow Jones
·
Jul 21

RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276

MT Newswires Live
·
Jul 17

ResMed downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Jul 16

ResMed price target lowered to $220 from $235 at Mizuho

TIPRANKS
·
Jul 15

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 15

Baird Adjusts ResMed Price Target to $217 From $225, Maintains Neutral Rating

MT Newswires Live
·
Jul 14

Cleveland Medical Devices: Won Favorable Ptab Outcomes in 5 of 6 Resmed Ipr Challenges

THOMSON REUTERS
·
Jul 14

Cleveland Medical Devices: in Four of Five Proceedings, Ptab Determined That Co Had not Established That Challenged Claims were Unpatentable

THOMSON REUTERS
·
Jul 14

Movement Alert|ResMed Falls 5.61% in Regular Trading, Citi Downgrades Rating to Neutral Triggering Sell-Off

Market Focus
·
Jul 13

Movement Alert|ResMed Falls 5.19% in Pre-Market Trading, Citi Downgrades Rating to Neutral

Market Focus
·
Jul 13

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 13

Resmed Cut to Neutral from Buy by Citigroup

Dow Jones
·
Jul 13

3 US Healthcare Stocks Investors May Revisit As Inflation Pressures Build

Simply Wall St.
·
Jul 13

Citi Downgrades ResMed to Neutral From Buy; Price Target is AU$34

MT Newswires Live
·
Jul 13

ResMed downgraded to Neutral from Buy at Citi

TIPRANKS
·
Jul 13

Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Eli Lilly & Co (LLY)

TIPRANKS
·
Jul 13

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 11

Resmed is Maintained at Hold by Jefferies

Dow Jones
·
Jul 11